Log In
Print
BCIQ
Print
Print this Print this
 

formerly GVAX Melanoma vaccine

Also known as: BioSante melanoma vaccine

  Manage Alerts
Collapse Summary General Information
Company Aduro BioTech Inc.
DescriptionAllogeneic cancer vaccine engineered to secrete granulocyte macrophage colony-stimulating factor (GM-CSF)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationMelanoma
Indication DetailsTreat IIb-IV stage melanoma
Regulatory Designation

U.S. - Orphan Drug (Treat IIb-IV stage melanoma)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today